Thursday, June 16, 2016

BRIEF-Aerie Pharma completes enrollment of phase 3 clinical trial of eye drug Rhopressa

* Trial on track for topline 90-day interim efficacy readout

in q4 2016

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)